Background: Neuroimaging methods including fMRI provide powerful tools to observe whole-30 brain functional networks. This is particularly powerful in animal models, allowing these 31 networks to be probed using complementary methods. However, most animals must be 32 anesthetized for neuroimaging, giving rise to complications resulting from anesthetic effects on 33 the animal's physiological and neurological functions. For example, an established protocol for 34 feline neuroimaging involves co-administration of ketamine and isoflurane -the latter of which 35 is known to suppress cortical function. 36 37 New Method: Here, we compare this established protocol to alfaxalone, a single-agent 38 anesthetic for functional neuroimaging. We first compare the two in a controlled environment 39 to assess relative safety and to measure physiological stability over an extended time window. 40 We then compare patterns of auditory and visually-evoked activity measured at 7T to assess 41 mean signal strength and between-subjects signal variability. 42 43 Results in Comparison with Existing Methods: We show that alfaxalone results in more stable 44 respiratory rates over the 120 minutes testing period, with evidence of smaller between 45 measurements variability within this time window, when compared to ketamine plus 46 isoflurane. Moreover, we demonstrate that both agents evoke similar mean BOLD signals 47 across animals, but that alfaxalone elicits more consistent BOLD activity in response to sound 48 stimuli across all ROIs observed. 49 50
* Correspondence should be addressed to: 23 Dr. Blake Butler Abstract: 29 Background: Neuroimaging methods including fMRI provide powerful tools to observe whole-30 brain functional networks. This is particularly powerful in animal models, allowing these 31 networks to be probed using complementary methods. However, most animals must be 32 anesthetized for neuroimaging, giving rise to complications resulting from anesthetic effects on 33 the animal's physiological and neurological functions. For example, an established protocol for 34 feline neuroimaging involves co-administration of ketamine and isoflurane -the latter of which 35 is known to suppress cortical function. 36 37 New Method: Here, we compare this established protocol to alfaxalone, a single-agent 38 anesthetic for functional neuroimaging. We first compare the two in a controlled environment 39 to assess relative safety and to measure physiological stability over an extended time window. 40 We then compare patterns of auditory and visually-evoked activity measured at 7T to assess 41 mean signal strength and between-subjects signal variability. 42 43 Results in Comparison with Existing Methods: We show that alfaxalone results in more stable 44 respiratory rates over the 120 minutes testing period, with evidence of smaller between 45 measurements variability within this time window, when compared to ketamine plus 46 isoflurane. Moreover, we demonstrate that both agents evoke similar mean BOLD signals 47 across animals, but that alfaxalone elicits more consistent BOLD activity in response to sound 48 stimuli across all ROIs observed. 49 50 Conclusions: Alfaxalone is observed to be more physiologically stable, evoking a more 51 consistent BOLD signal across animals than the co-administration of ketamine and isoflurane. 52 Thus, an alfaxalone-based protocol may represent a better approach for neuroimaging in 53 animal models requiring anesthesia. 58 Experiments in animal models continue to be critical for understanding the structure 59 and function of the brain. For decades, cats have been successfully used as an animal model to 60 study sensory systems, largely due to the remarkable similarities that they share with human 61 cell types, neural pathways, and cytoarchitecture (Blake, 1979) . Electrophysiological 66 systems, and the interactions between the two. 67 Recently, there has been increased interest in non-invasive neuroimaging methods like 68 functional magnetic resonance imaging (fMRI) for the study of sensory system function in 69 animal models. This approach offers several advantages, including the ability to examine 70 perception at the whole-brain level, and the ability to undertake longitudinal, within-animal 71 studies of sensory system development (which in turn aids in reducing the number of animals 72 required to power meaningful comparisons). This offers a distinct advantage over other 73 methods such as electrophysiological studies, which are highly invasive and are limited in their 74 capacity to evaluate processes occurring over spatially disparate neural networks. fMRI 75 measures changes in the ratio of oxygenated to deoxygenated blood, or blood-oxygen-level-76 dependent (BOLD) signals (Ogawa et al., 1990 ). An increase in this BOLD signal is thought to 77 reflect increased neuronal activity compared to a baseline measurement (Buxton and Frank, 78 1997; Logothetis et al., 2001; Ferris et al., 2006) . Moreover, by measuring the temporal 79 coherence of the BOLD signal across spatially disparate areas of the brain, it is possible to 80 estimate the degree to which these areas are functionally connected into networks that 81 support perception and associated behaviors. 82 Modern fMRI scanners can provide spatial resolution with 1 mm precision, but the 83 accuracy of these measures depends critically on minimizing subject movement within the 84 scanner. While most human participants can be instructed to remain still during imaging 85 sessions, this is not possible in most other animals, and meaningful measurements must thus 86 4 be taken under anesthesia. Anesthetic agents help minimize potential stress and fluctuations in 87 behavior that can affect the quality of data retrieved. However, the use of anesthetics during 88 fMRI necessitates due consideration be given to the effects of the drugs themselves (Ueki et examination of resting-state connectivity using fMRI (Stolzberg et al., 2018) . 118 In spite of successive revisions, the combination of isoflurane and ketamine is known to 119 result in widespread cortical deactivation in other animals (e.g. Hodkinson et al., 2012). 120 Moreover, these effects appear to differ by brain region/sensory modality such that the co-121 administration of ketamine and isoflurane may limit the ability to study sensory processes Several potential agents were considered in the current study with important limitations 127 in mind. In addition to the complications related to isoflurane described above, ketamine is 128 known to be a dissociative agent, disrupting the central nervous system and causing a cataleptic 129 state with dose-dependent hallucinations; thus, some protocols in routine use (e.g. ketamine 130 plus diazepam/midazolam/xylazine) were deemed suboptimal for sensory-evoked 131 neuroimaging. Moreover, a single-agent approach was considered practical in order to avoid 132 complications inherent to maintaining a stable level of anesthesia during dynamic and complex 133 drug interactions (an assumption critical to interpreting neuroimaging data averaged over 134 extended time periods). In addition, many agents were excluded because their mechanism of 135 action was deemed not conducive for measuring BOLD signals (Table 1) . Others were 136 eliminated in consultation with veterinary care staff due to concerns with respect to 137 physiological effects. As a result, alfaxalone was considered to be the strongest candidate 138 protocol to serve as an alternative to the coadministration of ketamine and isoflurane as a To examine whether a global difference in BOLD signal amplitude exists between 346 anesthetics, normalized percent BOLD signal changes (hereafter referred to as BOLD signals) 347 were extracted from all selected ROIs, in each animal. 348 As an initial test, a mixed ANOVA was performed on these BOLD signals, where 349 anesthetic protocol (Iso+Ket/Alf) was treated as a between-subjects factor, and within-subject 
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